Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 7/20 | 0.40 |
| ▸ | PDE5A | O76074 | 6/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 4/20 | 0.40 |
| ▸ | MIF | P14174 | 2/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30885826 | 0.82 | PDE4B (0.43) | PDE4BPDE5APDE3AMIFADORA2A | |
| SCHEMBL6489458 | 0.77 | PDE4B (0.58) | PDE4BPDE5APDE3AMIFADORA2A | |
| SCHEMBL20654243 | 0.73 | MIF (0.43) | PDE4BPDE5APDE3AMIFADORA2A | |
| SCHEMBL6490727 | 0.73 | PDE5A (0.44) | PDE4BPDE5APDE3AMIFADORA2A | |
| SCHEMBL6629043 | 0.72 | ALDH1A1 (0.36) | PDE4BPDE5APDE3AMIFADORA2A | |
| SCHEMBL19700226 | 0.70 | EGFR (0.49) | PDE4BPDE5APDE3AMIFADORA2A | |
| SCHEMBL30885843 | 0.69 | ALDH1A1 (0.34) | PDE4BPDE5APDE3AMIFADORA2A | |
| Formamide SCHEMBL15017827 | 0.68 | PDE5A (0.41) | PDE4BPDE5APDE3AMIFADORA2A | |
| SCHEMBL35212140 | 0.68 | MIF (0.41) | PDE4BPDE5APDE3AMIFADORA2A | |
| SCHEMBL6494096 | 0.67 | ALDH1A1 (0.38) | PDE4BPDE5APDE3AMIFADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125366-A1 | METHODS FOR TREATING CANCER | SCORPION THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125366-A1 | METHODS FOR TREATING CANCER | AKT2, AKT3, PIK3R5 | PDE4B 1028/4885PDE5A 944/4885PDE3A 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.